<?xml version="1.0" encoding="UTF-8"?>
<ref id="B160-cancers-13-02036">
 <label>160.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Galtier</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sordi</surname>
    <given-names>L.D.</given-names>
   </name>
   <name>
    <surname>Sivignon</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>De Vallée</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Maura</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Neut</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Rahmouni</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Wannerberger</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Darfeuille-Michaud</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Desreumaux</surname>
    <given-names>P.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Bacteriophages Targeting adherent invasive escherichia coli strains as a promising new treatment for crohn’s disease</article-title>
  <source>J. Crohn’s Colitis</source>
  <year>2017</year>
  <volume>11</volume>
  <fpage>840</fpage>
  <lpage>847</lpage>
  <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjw224</pub-id>
  <pub-id pub-id-type="pmid">28130329</pub-id>
 </element-citation>
</ref>
